首页|English |

邹鹏

目前主要围绕天然产物及其类似物,探讨这些化合物的作用机制及其相应的作用靶点。在Theranostics、Cancer Letters、Free Radical Biology and Medicine和Cellular Oncology等杂志发表SCI论文29篇,其中第一作者或通讯作者11篇(总IF大于70)。申请并授权专利1项。以第一指导老师获得大学生挑战杯浙江省一等奖一项。
姓名  邹鹏 性别  男
职称  副研究员 学位  博士研究生
职务   电子邮件  zoupeng@wmu.edu.cn

1.专业研究方向:抗肿瘤药物药理

2.教学成果:作为指导老师指导的本科生获浙江省挑战杯一等奖1项。

3.发表论文(具有代表性的3篇)

(1)Yiqun Xia,Jundixia Chen,Yun Yu,Fengjiao Wu,Xin Shen,Chenyu Qiu,Tingting Zhang,Lin Hong,Peisen Zheng,Rongrong Shao,Chenxin Xu,Fang Wu,Wei Chen,Congying Xie,Ri Cui,Peng Zou.Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors.Theranostics. 2021, 11(9):4335-4350.

(2)Guang Liang,Wei Meng,Xiangjie Huang,Wangyu Zhu,Changtian Yin,Canwei Wang,Matteo Fassan,Yun Yu,Masahisa Kudo,Sisi Xiao,Chengguang Zhao,Peng Zou,Yumin Wang,Xiaokun Li,Carlo M Croce,Ri Cui. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.Proc Natl Acad Sci U S A. 2020, 117(8):4347-4357.

(3)Tingting Zhang, Peisen Zheng, Xin Shen, Rongrong Shao, Bin Wang, Huanpei Shen, Jingjing Zhang, Yiqun Xia,Peng Zou. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.Free Radic Biol Med. 2019, 141:93-102.



关闭